Innovative MedTech, Inc., on April 18, 2024, terminated Merle Griff, PhD., as the Company?s CEO, and Michael Friedman, the Company?s President and CFO, was appointed as CEO of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6795 USD | +9.60% | +9.60% | -9.40% |
05-20 | Innovative MedTech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
04-22 | Innovative Medtech, Inc. Announces Chief Executive Officer Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-9.40% | 16.23M | |
+3.68% | 10.33B | |
+3.89% | 2.85B | |
-20.02% | 2.21B | |
+2.97% | 2.04B | |
+10.77% | 1.15B | |
+100.00% | 1.04B | |
-9.24% | 1.02B | |
-3.52% | 722M | |
-42.32% | 691M |
- Stock Market
- Equities
- IMTH Stock
- News Innovative MedTech, Inc.
- Innovative Medtech, Inc. Announces Chief Executive Officer Changes